Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone for Abdominal Fat in HIV-Positive Men
NCT00009555Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in abdominal obesity and Hypogonadism comparing Testosterone with Placebo (2 arms). Primary endpoint: Changes in visceral fat at 48 weeks. Status: completed.
02
Drugs
testosterone
03
Conditions
abdominal obesityHypogonadism
Beyond the preview
Go deeper on NCT00009555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009555.